Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of EUR 58.97 billion. The enterprise value is 77.74 billion.
Market Cap | 58.97B |
Enterprise Value | 77.74B |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
Earnings Date | Jul 16, 2025 |
Ex-Dividend Date | Jun 10, 2025 |
Share Statistics
Current Share Class | 225.93M |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.43% |
Shares Change (QoQ) | -0.62% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 225.42M |
Valuation Ratios
The trailing PE ratio is 12.92 and the forward PE ratio is 8.63.
PE Ratio | 12.92 |
Forward PE | 8.63 |
PS Ratio | 0.37 |
PB Ratio | 1.58 |
P/TBV Ratio | 17.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.41, with an EV/FCF ratio of 17.11.
EV / Earnings | 17.03 |
EV / Sales | 0.48 |
EV / EBITDA | 9.41 |
EV / EBIT | 10.43 |
EV / FCF | 17.11 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.44 |
Quick Ratio | 1.32 |
Debt / Equity | 0.69 |
Debt / EBITDA | 3.15 |
Debt / FCF | 5.66 |
Interest Coverage | 6.52 |
Financial Efficiency
Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 7.36%.
Return on Equity (ROE) | 12.42% |
Return on Assets (ROA) | 4.60% |
Return on Invested Capital (ROIC) | 7.36% |
Return on Capital Employed (ROCE) | 11.06% |
Revenue Per Employee | 1.55M |
Profits Per Employee | 43,801 |
Employee Count | 104,200 |
Asset Turnover | 1.61 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid 1.46 billion in taxes.
Income Tax | 1.46B |
Effective Tax Rate | 24.32% |
Stock Price Statistics
The stock price has decreased by -39.51% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -39.51% |
50-Day Moving Average | 326.97 |
200-Day Moving Average | 370.02 |
Relative Strength Index (RSI) | 38.07 |
Average Volume (20 Days) | 7 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, Elevance Health had revenue of EUR 161.15 billion and earned 4.56 billion in profits. Earnings per share was 19.91.
Revenue | 161.15B |
Gross Profit | 43.25B |
Operating Income | 7.36B |
Pretax Income | 6.02B |
Net Income | 4.56B |
EBITDA | 7.99B |
EBIT | 7.36B |
Earnings Per Share (EPS) | 19.91 |
Balance Sheet
The company has 29.63 billion in cash and 25.70 billion in debt, giving a net cash position of -18.41 billion.
Cash & Cash Equivalents | 29.63B |
Total Debt | 25.70B |
Net Cash | -18.41B |
Net Cash Per Share | n/a |
Equity (Book Value) | 37.34B |
Book Value Per Share | 164.88 |
Working Capital | 16.60B |
Cash Flow
In the last 12 months, operating cash flow was 5.50 billion and capital expenditures -951.13 million, giving a free cash flow of 4.54 billion.
Operating Cash Flow | 5.50B |
Capital Expenditures | -951.13M |
Free Cash Flow | 4.54B |
FCF Per Share | n/a |
Margins
Gross margin is 26.84%, with operating and profit margins of 4.56% and 2.83%.
Gross Margin | 26.84% |
Operating Margin | 4.56% |
Pretax Margin | 3.73% |
Profit Margin | 2.83% |
EBITDA Margin | 4.96% |
EBIT Margin | 4.56% |
FCF Margin | 2.82% |
Dividends & Yields
This stock pays an annual dividend of 6.10, which amounts to a dividend yield of 2.08%.
Dividend Per Share | 6.10 |
Dividend Yield | 2.08% |
Dividend Growth (YoY) | 6.00% |
Years of Dividend Growth | 6 |
Payout Ratio | 28.40% |
Buyback Yield | 2.43% |
Shareholder Yield | 4.50% |
Earnings Yield | 7.74% |
FCF Yield | 7.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |